Loading

Journal of Clinical Nephrology and Research

Nephrotic Syndrome and Acute Tubular Necrosis and Interstitial Nephritis Associated with Diclofenac

Case Report | Open Access | Volume 5 | Issue 1

  • 1. Department of Nephrology, Peking University International Hospital, China
+ Show More - Show Less
Corresponding Authors
Mei Wang, Nephrology Department, Peking University International Hospital, Zhongguancun Lifescience Park, Changping, Peking, China, Tel: 86010-69006549
Abstract

Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are a kind of drugs used worldwide. Renal damages induced by NSAIDs are frequently reported in China. But its reported case of the coexistence of nephrotic syndrome (NS), acute tubular necrosis (ATN) and acute interstitial nephritis (AIN) is limited.

Case diagnosis/treatment: A case of a 59-year-old man, in July 28, 2016, presented with increasing fatigue, edema of legs, anuria and deterioration in renal function after the oral diclofenac. A renal biopsy revealed minimal change disease (MCD) with ATN and mild AIN. The history of use of diclofenac and the renal biopsy led to a diagnosis of MCD with ATN and AIN caused by NSAIDs. The patient’s urine volume and the renal function improved slowly after taking oral corticosteroids for 6 weeks. The serum creatinine level recovered completely 10 weeks later. However the 24-hour urine protein excretion increased to 11g with the improvement of renal function. We gave oral administration of cyclophosphamide 50mg/d, thereafter 24-hour urine protein excretion decreased to 0.2g/d. This is a rare case of MCD with AIN and ATN associated with the use of NSAIDs.

Conclusions: This case makes us understand the kidney damages caused by NSAIDs drugs more deeply. We should give considerable concern with side effect of NSAIDs.
 

Keywords

 •    Non-steroidal anti-inflammatory drugs •    Diclofenac •    Acute renal failure •    Minimal change disease •    Acute tubular necrosis •    Acute interstitial nephritis

CITATION

Luo Y, Wang M (2018) Nephrotic Syndrome and Acute Tubular Necrosis and Interstitial Nephritis Associated with Diclofenac. J Clin Nephrol Res 5(1): 1083.

ABBREVIATIONS

NSAIDs: Non-Steroidal Anti-Inflammatory Drugs; ARF: Acute Renal Failure; MCD: Minimal Change Disease; ATN: Acute Tubular Necrosis; AIN: Acute Interstitial Nephritis

INTRODUCTION

NSAIDs are a kind of drugs different from glucocorticoids, which is widely used to treat a variety of fever and acute and chronic pains worldwide. It is one of the most commonly prescribed drugs [1,2]. In addition, most Chinese follows the principle of self-treatment with these analgesics due to the convenience of over-the-counter availability of these drugs. In the United States, about 1 million people suffer different side effects of the NSAIDs drug toxicity each year. The incidence of adverse reactions is about 1~5% in the population of using these drugs [3]. The most seriously life-threatening complications are the upper gastrointestinal bleeding and the acute renal failure. Renal damages induced by NSAIDs are frequently reported in China. We are highlighting here a case of biopsy-proven minimal change disease (MCD) with ATN and AIN for a patient who was aware of a similar ‘harmless and necessary’ painkiller. This is a rare case report associated with the use of NSAIDs. Moreover, the recovery of AKI in this case is very slowly. The coexistence of ATN and AIN could delay the recovery of renal function. This case makes us understand the kidney damages caused by NSAIDs drugs more deeply.

CASE PRESENTATION

This is a 59-year-old man, who was previously in good health and had no significant past medicinal history. History-taking disclosed that he took diclofenac 30mg/d for 3 days because of a headache 35 days ago.18 days ago, he began to have anorexia, fatigue, eyelids and double legs pitting edema, although his urine volume was not significantly reduced.10 days ago, there was a significant decrease in urine volume, 400~600ml/d, and his anorexia and edema were more severe accompanied with nausea and vomiting. He had no fever, skin rash and joints pain, etc. He went to see doctors in a local hospital. A urinalysis indicated a gravity of 1.021 and 600mg/dl proteinuria, sugar ±, leukocyte 20~25/HP, red blood cell 3~7/HP. Blood analysis revealed the white blood cell count and classification, the platelet count were normal, hemoglobin 127g/L. Serum creatinine was 307.3umol/l, Albumin 35g/l, blood urea 15.24mmol/L. The blood glucose, the blood lipid and the liver function were all normal. Meanwhile, the ultrasound showed that the sizes of the two kidneys were normal, and there was no renal pelvis dilatation. 7 days ago the urine volume was further reduced, and serum creatinine concentration was increased to 363umol/l with a blood urea 21.9mmol/L. The patient was treated with hemodialysis in local hospital. Later, he was transferred to our hospital for further diagnosis and treatment. There was no other medicinal history except for smoking for more than 20 years.

Physical examination

T: 36.8, P: 82/min, R: 16/min, BP: 140/90mmHg. The general condition was good. There was mild eyelids edema, no conjunctiva pale and jugular venous engorgement, no abnormal findings in heart, lungs and abdomen. But severe symmetric pitting edema of both legs was found.

Investigations

Urinalysis: sugar +, protein: 4+, leukocytes 2989/µl, red blood cells 157/µl. Urinary white cell classification: lymphocytes 57%, monocytes 29% Neutrophils 13% eosinophils1%. NAG 19.3U/L ↑. Microscopy for urinary sediment: a large number of thin and long coarse granular casts and waxy casts were presented, most of which were waxy casts. We could find significant number of renal tubular epithelial cell casts and occasionally red blood cell casts. Blood routine test: white blood cell 8.91x109 /L (percentage of neutrophils, lymphocytes and eosinophils 68.1%, L19.9%, 2.19%, respectively; eosinophil count 0.19x109 /L), hemoglobin 102g/L↓, platelet 190x109 /L. Serum biochemical test: albumin 28.9g/L↓, blood urea 19.81mmol/L↑, creatinine 1261umol/ L↑, eGFR 3.3ml/min/1.73m2 ↓, potassium 3.3mmol/L↓ sodium 140mmol/L, calcium 2.47mmol/L, phosphorus 0.48mmol/L↓, Cholesterol 3.46mmol/L, Triglyceride 1.23mmol/L, Fasting glucose 4.70mmol/L, serum IgE 263IU/ml↑. Abdominal ultrasonography: The left kidney sizes 10.9×6.4×5.5cm the right one is 11.6×5.5×5.7cm. The thickness of the renal parenchyma is 22mm (left) and 20mm (right) respectively. Echo enhancement of double renal parenchyma was found.

Case analysis

With a sudden onset, the state of this patient rapidly progressed to oliguria and anuria. The normal size of double kidneys and the mild lower hemoglobin suggested the possibility of acute renal failure (ARF). According to the history of taking NSAIDs (diclofenac) drugs, and numerous coarse granular casts and waxy casts and renal tubular epithelial cell casts in the urine, we considered the high possibility of ATN. However the duration between taking diclofenac and the onset of AKI was very long. The large number of white blood cells in the urine, mainly lymphocytes, could not support a simple ATN. The glucose level in blood was normal but positive in urine, which indicated the possibility of AIN. But the patient had no fever, no skin rash, no joints pain and any allergic manifestations, and blood eosinophil are not high. Meanwhile the patient revealed a heavy proteinuria, which was not the characteristics of the ATN and AIN, but was a clue of glomerular disease. Later, we tested the ANCA and the anti GBM antibodies, both negative. Also, the blood and urine immunoglobulin light chain protein were negative. The level of serum immunoglobulins (IgA, IgG, IgM) and complements were all normal. Although the level of serum IgE was significantly increased. For further diagnosis and treatment, the renal biopsy was performed.

Renal histopathology

Light microscopy: There were 19 glomeruli in the specimen. Except a sclerosed glomerulus and slight glomerular basement membrane vacuolar degeneration, no obvious pathological changes were observed (Figure 1).

Light micrograph showing slight glomerular basement  membrane vacuolar degeneration, no obvious pathological change was  observed in glomeruli. The renal tubular epithelial cells multiple focal  brush hair loss (black arrow) and the cell debris in the lumen could be  seen (solid arrow). (periodic acid-Schiff, original magnification ×200).

Figure 1 Light micrograph showing slight glomerular basement membrane vacuolar degeneration, no obvious pathological change was observed in glomeruli. The renal tubular epithelial cells multiple focal brush hair loss (black arrow) and the cell debris in the lumen could be seen (solid arrow). (periodic acid-Schiff, original magnification ×200).

The renal tubular epithelial cells were vacuolar degeneration, and multiple focal brush hair loss. Tubular cell debris in the lumen could be seen. The renal interstitial was edema. There were focal interstitial inflammatory cells Infiltrates, predominantly lymphocytes and mononuclear cells, and a small amount of eosinophil (Figure 2a, 2b).

Light micrograph shows the renal tubular epithelial cells  vacuolar degeneration (solid arrow). The renal interstitial was  edema. There were focal interstitial inflammatory cells Infiltrates,  predominantly lymphocytes and mononuclear cells, and a small  amount of eosinophils (black arrow). Periodic acid-Schiff, original  magnification.

Figure 2 Light micrograph shows the renal tubular epithelial cells vacuolar degeneration (solid arrow). The renal interstitial was edema. There were focal interstitial inflammatory cells Infiltrates, predominantly lymphocytes and mononuclear cells, and a small amount of eosinophils (black arrow). Periodic acid-Schiff, original magnification.

The thickness of the small arteries showed slight increment.

Immunofluorescence microscopy: C3+~++, IgA-, IgG-, IgM- , FRA-C1q-.Weak C3 mainly deposited in glomerular mesangial region, there was no C3 deposition in the tuberlar region.

Electron microscopy: Diffused effacement of the glomerular foot processes was showed. There were no immune complex deposits or basement membrane abnormalities (Figure 3).

Electron micrograph shows the focal effacement of  glomerular foot processes (black arrows) without deposits or  basement abnormalities (original magnification ×5,000).

Figure 3 Electron micrograph shows the focal effacement of glomerular foot processes (black arrows) without deposits or basement abnormalities (original magnification ×5,000).

Diagnosis: Based on the clinical and the pathologic manifestations, the final diagnosis was MCD with ATN and AIN, likely caused by NSAIDs.

Treatments: We gave the patient hemodialysis, glucocorticoids (60mg/d, body weight 75kg) and some supportive therapy. After 6 weeks of treatments, the patient’s urine volume began to increase, and the laboratory data demonstrated a decreased serum creatinine. At the 8th week, the hemodialysis therapy was discontinued and at the 10th week, the serum creatinine level returned to normal and his urine volume arrived at 1200-1700ml/d, without a typical polyuria stage. At the same time, 24h urinary protein excretion was increased gradually with an increase of urine volume, up to 11g/d (most of them albumin). The serum albumin level was reduced from 28.9g/L to 19.8g/L. So we combined cyclophosphamide 50mg/d with glucocorticoid. At the 11th week (1 week after the use of cyclophosphamide), 24h urinary protein excretion was reduced from 11g/d to 2.4-3.5g/d. At 14th week, the serum albumin concentration was elevated to 35g/L. The 24h urinary protein excretion was reduced to 1.0g/d. We called this patient at the 18th week. The 24h urinary protein excretion was reduced to 0.2g/d.

DISCUSSION

The renal damages induced by NSAIDs can often be reported, including ATN, AIN and nephrotic syndrome (mainly MCD and membranous nephropathy). But two kinds of damages occur in the same patient simultaneously is very rarely. In 2002, Alper AB Jr and his colleagues reported a case of MCD with AIN induced by celecoxib [4]. In 2008, Galeši? K et al., reported a case of MCD with ATN induced by diclofenac [5]. In 2014, Hiroaki K found a case of MCD with AIN induced by topical application of loxoprofen patch [6].

This case is rarely reported for glomerular MCD with ATN and AIN caused by NSAIDs.

What is the mechanism behind the kidney damage caused by NSAIDs drugs? Normally, the arachidonic acid (AA) is catalyzed by cyclooxygenase (COXs) to form prostaglandins (PGs), and by lipoxygenase (LOs) to form leukotrienes (LTs). PGs mediate the biological effect of dilating blood vessels. However, LTs has a strong effect on the contraction of blood vessels. Diclofenac inhibits the activity of COXs to interfere the synthesis metabolism of PGs and LTs from AA.

On one hand, NSAIDs mediate AKI by hemodynamic mechanism. There is a variety of tissue COXs in kidney glomerular, tubular and interstitial cells, mainly producing 5 kinds of PGs products (PGD2, PGE2, PGF2, PGI2 and TXA2). These native PGs of kidney mainly induce the dilating of blood vessels, maintain the renal perfusion, reduce the ischemic injury [7], especially under stress conditions. When the COXs are blocked by NSAIDs drugs, the reduction of PGs level in the local tissue of the kidney attenuates the ability of adjusting blood flow, resulting in renal ischemia ultimately. Patients often show a rapid increase in serum creatinine generally 3~7 days after taking the drug. Because a high and stable drug concentration in blood needs a period of accumulation firstly, and then largely affects the inhibition of COXs. In case of ATN induced by hemodynamic disorder, there are no significantly red blood cells in urine under microscopy. In addition, the urine protein level is low (mostly lower than 500mg/d). Also the renal tubular epithelial cell casts may be found. The key point to distinguish ATN from AIN is no white blood cells for the former one and the white blood cells casts in the urine for the latter.

On the other hand, NSAIDs may mediate AIN and nephrotic syndrome by immunological mechanism. The common pathological types of glomerular disease were MCD and membranous nephropathy. It is considered as nondose-dependent. As a kind of inflammatory factors, LTs have chemotaxis to inflammatory cells, which causes the infiltration of inflammatory cells in the kidney interstitial tissue. The increased concentration of LTs and various inflammatory cytokines released by inflammatory cells both increase the permeability of glomerular basement membrane, thereby, result in the proteinuria even nephrotic syndrome. Typical AIN offen appears obvious hematuria, leukocyturia/pyuria and rapid elevation in serum creatinine. In our case the systemic allergic reactions are atypical. There are parts of the performance including the urine white blood cells, mainly lymphocytes and monocytes, and positive urine glucose (normal blood glucose), significantly increased the serum IgE. These supported a diagnosis of AIN. Thereafter, the renal biopsy confirmed the existence of interstitial nephritis.

It is reported that simple AIN or ATN induced by NSAIDs drug remit within 6 weeks after the withdrawal of NSAIDs and the treatment with glucocorticoid [5-7]. But the recovery of AKI in this case is very slowly. After 9 weeks, the volume of urine of the patient began to increase. But, there is no polyuria stage after that. Following a long treatment of 13 weeks, the renal function eventually returned to normal. The coexistence of ATN, AIN and NS delay the recovery of renal function. Besides, the atherosclerosis in the renal small arteries can also delay the recovery of the renal failure. The factors above make the renal tubular epithelial cells regenerate slowly, and the renal tubular reconstruction is prolonged. Therefore, the urine volume could not increase rapidly.

Luo Y, Wang M (2018) Nephrotic Syndrome and Acute Tubular Necrosis and Interstitial Nephritis Associated with Diclofenac. J Clin Nephrol Res 5(1): 1083.

Received : 25 Jan 2018
Accepted : 22 Feb 2018
Published : 26 Feb 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X